Preferred Name |
Glipalamide |
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72797 |
CAS_Registry |
37598-94-0 |
Chemical_Formula |
C12H15N3O3S |
code |
C72797 |
Concept_In_Subset | |
Contributing_Source |
FDA |
DEFINITION |
A second-generation sulfonamide derivative with antihyperglycemic activity. Like other sulfonylureas, glipalamide exerts extra-pancreatic activity, such as increased binding of insulin to insulin receptors on adipocytes. |
FDA_UNII_Code |
W7J490CUHM |
FULL_SYN |
3-Methyl-N-(4-methylphenyl)sulfonyl-3,4-dihydropyrazole-2-carboxamide SPC-703 4,5-Dihydro-5-methyl-N-((4-methylphenyl)sulfonyl)-1H-pyrazole-1-carboxamide |
label |
Glipalamide |
Legacy_Concept_Name |
Glipalamide |
Preferred_Name |
Glipalamide |
prefixIRI |
C72797 |
prefLabel |
Glipalamide |
Semantic_Type |
Pharmacologic Substance |
UMLS_CUI |
C0243356 |
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/MESH/C009971 | Medical Subject Headings | LOOM |